Advanced

Hypothermia for Stroke: call to action 2010

Macleod, Malcolm R.; Petersson, Jesper LU ; Norrving, Bo LU ; Hacke, Werner; Dirnagl, Ulrich; Wagner, Markus and Schwab, Stefan (2010) In International Journal of Stroke 5(6). p.489-492
Abstract
The European Hypothermia Stroke Research Workshop was held in January 2010, in response to the alarming prospects of a significant increase of stroke expected in the coming years globally. Considering that a minority of patients (around 10%) are currently eligible for thrombolytic treatment, there is a need for an efficacious, cost-effective novel therapy that can be implemented broadly within European health care systems. Accordingly, the primary objective of the workshop was the definition of a research agenda aiming to assess the therapeutic benefits of hypothermia in patients with acute ischaemic stroke. The meeting was organised by the European Stroke Research Network for Hypothermia(EuroHyp) and attended by the representatives of... (More)
The European Hypothermia Stroke Research Workshop was held in January 2010, in response to the alarming prospects of a significant increase of stroke expected in the coming years globally. Considering that a minority of patients (around 10%) are currently eligible for thrombolytic treatment, there is a need for an efficacious, cost-effective novel therapy that can be implemented broadly within European health care systems. Accordingly, the primary objective of the workshop was the definition of a research agenda aiming to assess the therapeutic benefits of hypothermia in patients with acute ischaemic stroke. The meeting was organised by the European Stroke Research Network for Hypothermia(EuroHyp) and attended by the representatives of World Stroke Organisation, European Stroke Organisation, Stroke Alliance for Europe, Society for Cryobiology and other organisations - specifically the European Space Agency, and small-and medium-sized enterprises based in EU member states. The participants adopted the 'Hypothermia for Stroke - Call to Action 2010', a declaration specifying the priorities for hypothermia research in acute ischaemic stroke. The research programme outlined - a clinical study programme designed to identify and validate therapeutic cooling as a novel treatment providing benefit to a large number of stroke patients-contains a well-integrated series of Phase II studies aiming to refine the intervention (depth, duration, and mode of cooling; antishivering strategy; patient selection) and a pivotal Phase III clinical trial. The proposed integrated Phase II and III clinical study programme would test the effectiveness of this optimised intervention, and would allow the development of evidence-based Clinical Practice Guidelines describing the optimal use of therapeutic hypothermia as a treatment strategy for stroke. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
ischaemic stroke, intervention, hypothermia, acute stroke therapy, clinical trial, neuroprotection
in
International Journal of Stroke
volume
5
issue
6
pages
489 - 492
publisher
Wiley-Blackwell
external identifiers
  • wos:000283949400013
  • scopus:78149490924
ISSN
1747-4949
DOI
10.1111/j.1747-4949.2010.00520.x
language
English
LU publication?
yes
id
acbdfc71-eeef-4075-9dd9-1d0c2c884f66 (old id 1752193)
date added to LUP
2011-01-04 07:43:48
date last changed
2018-05-29 09:27:50
@article{acbdfc71-eeef-4075-9dd9-1d0c2c884f66,
  abstract     = {The European Hypothermia Stroke Research Workshop was held in January 2010, in response to the alarming prospects of a significant increase of stroke expected in the coming years globally. Considering that a minority of patients (around 10%) are currently eligible for thrombolytic treatment, there is a need for an efficacious, cost-effective novel therapy that can be implemented broadly within European health care systems. Accordingly, the primary objective of the workshop was the definition of a research agenda aiming to assess the therapeutic benefits of hypothermia in patients with acute ischaemic stroke. The meeting was organised by the European Stroke Research Network for Hypothermia(EuroHyp) and attended by the representatives of World Stroke Organisation, European Stroke Organisation, Stroke Alliance for Europe, Society for Cryobiology and other organisations - specifically the European Space Agency, and small-and medium-sized enterprises based in EU member states. The participants adopted the 'Hypothermia for Stroke - Call to Action 2010', a declaration specifying the priorities for hypothermia research in acute ischaemic stroke. The research programme outlined - a clinical study programme designed to identify and validate therapeutic cooling as a novel treatment providing benefit to a large number of stroke patients-contains a well-integrated series of Phase II studies aiming to refine the intervention (depth, duration, and mode of cooling; antishivering strategy; patient selection) and a pivotal Phase III clinical trial. The proposed integrated Phase II and III clinical study programme would test the effectiveness of this optimised intervention, and would allow the development of evidence-based Clinical Practice Guidelines describing the optimal use of therapeutic hypothermia as a treatment strategy for stroke.},
  author       = {Macleod, Malcolm R. and Petersson, Jesper and Norrving, Bo and Hacke, Werner and Dirnagl, Ulrich and Wagner, Markus and Schwab, Stefan},
  issn         = {1747-4949},
  keyword      = {ischaemic stroke,intervention,hypothermia,acute stroke therapy,clinical trial,neuroprotection},
  language     = {eng},
  number       = {6},
  pages        = {489--492},
  publisher    = {Wiley-Blackwell},
  series       = {International Journal of Stroke},
  title        = {Hypothermia for Stroke: call to action 2010},
  url          = {http://dx.doi.org/10.1111/j.1747-4949.2010.00520.x},
  volume       = {5},
  year         = {2010},
}